CDC7 and neoplasm: TAK-931 is a CDC7-selective kinase inhibitor that has anti-proliferative activity across various cancer cell lines and causes tumor growth inhibition in multiple cancer xenograft models, including human colorectal, lung, ovarian, and pancreatic cancer37.